Proactive Investors - Run By Investors For Investors

ANGLE PLC boss 'absolutely delighted' with results from pelvic mass study

ANGLE plc (LON:AGL,OTCQX:ANPCY) founder and chief executive Andrew Newland tells Proactive their ground-breaking liquid biopsy has outperformed current tests used to tell whether a pelvic mass is malignant or benign.

 
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full AGL profile View Profile

ANGLE PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use